In 4 years, the rate of women receiving breast MRI nearly tripled, but it is underused in women most at risk for breast cancer and overused in women at average risk.
The use of oral contraceptives in women with BRCA1/2 mutations was associated with a reduced risk of ovarian cancer.
Accelerated approval of Perjeta (pertuzumab) was granted by the FDA as part of a complete treatment regimen for patients with early stage breast cancer before surgery.
Breast density laws ensure that women receive critical breast-health information, supporters say, but many of the laws broadly classify breast density and fail to account for varying levels of risk.
The use of 40 Gy in 15 fractions over 3 weeks is as effective and causes less damage to nearby tissue than a higher total dose of radiotherapy for breast cancer.
Researchers suggest that recommendations for the universal screening of breast cancer with mammography be reassessed.
Women with a history of cancer are nearly twice as likely to experience severe menopausal symptoms, according to the results of a new study.
The goals of care for patients with hormone receptor (HR)-positive advanced breast cancer include prolongation of disease-free and overall survival, amelioration of symptoms, and improvement in quality of life.
Metabolic syndrome is more likely to develop in postmenopausal survivors of breast cancer than in postmenopausal women who never had the disease.
Hypofractionated external beam WBI seems like a great option until the APBI data mature from NSABP 39/RTOG 0413. In the meantime, we will have to see whether the ACA’s mission to bend the cost curve in the face of added demand for cancer care will succeed and how our treatment decisions will be affected by this new healthcare model.